Genetic Basis of Altered Central Tolerance and Autoimmune Diseases: A Lesson from AIRE Mutations

REFERENCES

• Grammatikos A, Tsokos G. Immunodeficiency and autoimmunity: lessons from systemic lupus erythematosus. Trends Mol Med. 2012;18:101–108.
   PubMed Web of Science ®Google Scholar
• Pessach IM, Notarangelo L. X-linked primary immunodeficiencies as a bridge to better understanding X-chromosome related autoimmunity. J Autoimmun. 2009;33:17–24.
   PubMed Web of Science ®Google Scholar
• Madkaikar M, Mhattre S, Gupta M, Ghosh K. Advances in autoimmune lymphoproliferative syndromes. Eur J Haematol. 2011;87:1–9.
   PubMedGoogle Scholar
• De Berardinis P, Ombra MN, Buono C, Toraldo R, Vetrano F, Guardiola J. Long-term culture and T cell receptor analysis of T cell clones isolated from a patient with adenosine deaminase deficiency and type I diabetes. Clin Immunol Immunopathol. 1994;73:362–366.
   PubMedGoogle Scholar
• Sneller MC, Strans SE, Jaffe ES, A novel lymphoproliferative/autoimmune syndrome resembling murine Ipr/gld disease. J Clin Invest. 1992;90:334–341.
   PubMed Web of Science ®Google Scholar
• Fisher GH, Rosenberg FJ, Straus SE, Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell. 1995;81:935–946.
   PubMed Web of Science ®Google Scholar
• Puck JM, Rieux-Laucat F, Le Deist F. Autoimmune lymphoproliferative syndrome. In: Ochs H, Smith CIE, Puck JM, eds. Primary Immunodeficiency Diseases: A Molecular and Genetic Approach. New York: Oxford University Press; 2006: 326–341.
   Google Scholar
• Niemela JE, Lu L, Fleisher TA, Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis. Blood. 2011;117:2883–2886.
   PubMed Web of Science ®Google Scholar
• DeFranco S, Bonissoni S, Cerutti F, Defective function of Fas in patients with type 1 diabetes associated with other autoimmune diseases. Diabetes. 2001;50:483–488.
   Google Scholar
• Turbyville JC, Koneti Rao V. The autoimmune lymphoproliferative syndrome: a rare disorder providing clues about normal tolerance. Autoimmun Rev. 2010;9:488–493.
   PubMedGoogle Scholar
• Holzelova E, Vonarbourg C, Stolzenberg MC, Autoimmune lymphoproliferative syndrome with somatic Fas mutations. N Engl J Med. 2004;351:1409–1418.
   PubMed Web of Science ®Google Scholar
• Godfrey VL, Wilkinson JE, Russell LB. X-linked lymphoreticular disease in the scurfy (sf) mutant mouse. Am J Pathol. 1991;138:1379–1387.
   PubMed Web of Science ®Google Scholar
• Bennett CL, Ochs HD. IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena. Curr Opin Pediatr. 2001;13:533–538.
   PubMed Web of Science ®Google Scholar
• Wildin RS, Smyk-Pearson S, Filipovich AH. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet. 2002;39:537–545.
   PubMed Web of Science ®Google Scholar
• Bennett CL, Christie J, Ramsdell F, The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. 2001;27:20–21.
   PubMed Web of Science ®Google Scholar
• Gambineri E, Perroni L, Passerini L, Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity. J Allergy Clin Immunol. 2008;122:1105–1112.
   PubMedGoogle Scholar
• Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057–1061.
   PubMed Web of Science ®Google Scholar
• Bacchetta R, Gambineri E, Roncarolo MG. Role of regulatory T cells and FOXP3 in human diseases. J Allergy Clin Immunol. 2007;120:227–235.
   PubMed Web of Science ®Google Scholar
• Romagnani S. Immunological tolerance and autoimmunity. Intern Emerg Med. 2006;1:187–196.
   PubMed Web of Science ®Google Scholar
• Karube K, Ohshima K, Tsuchiya T, Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia/lymphoma cells. Br J Haematol. 2004;126:81–84.
   PubMed Web of Science ®Google Scholar
• Viguier M, Lemaître F, Verola O, Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol. 2004;173:1444–1453.
   PubMed Web of Science ®Google Scholar
• Berger CL, Tigelaar R, Cohen J, Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells. Blood. 2005;105:1640–1647.
   PubMed Web of Science ®Google Scholar
• Ormandy LA, Hillemann T, Wedemeyer H, Manns MP, Greten TF, Korangy F. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res. 2005;65:2457–2464.
   PubMed Web of Science ®Google Scholar
• Chatila TA. Role of regulatory T cells in human diseases. J Allergy Clin Immunol. 2005;116:949–959.
   PubMed Web of Science ®Google Scholar
• Roifman CM. Human IL-2 receptor alpha chain deficiency. Pediatr Res. 2000;48:6–11.
   PubMed Web of Science ®Google Scholar
• Miller JF. Immunological function of the thymus. Lancet. 1961;2:748–749.
   PubMed Web of Science ®Google Scholar
• Bleul CC, Boehm T. Chemokines define distinct microenvironments in the developing thymus. Eur J Immunol. 2000;30:3371–3379.
   PubMed Web of Science ®Google Scholar
• Liu C, Ueno T, Kuse S, The role of CCL21 in recruitment of T-precursor cells to fetal thymi. Blood. 2005;105:31–39.
   PubMed Web of Science ®Google Scholar
• Holländer GA, Wang B, Nichogiannopoulou A, Developmental control point in induction of thymic cortex regulated by a subpopulation of prothymocytes. Nature. 1995;373:350–353.
   PubMed Web of Science ®Google Scholar
• van Ewijk W, Hollander G, Terhorst C, Wang B. Stepwise development of thymic microenvironments in vivo is regulated by thymocyte subsets. Development. 2000;127:1583–1591.
   PubMed Web of Science ®Google Scholar
• Klug DB, Carter C, Gimenez-Conti IB, Richie ER. Cutting edge: thymocyte-independent and thymocyte-dependent phases of epithelial patterning in the fetal thymus. J Immunol. 2002;169:2842–2845.
   PubMed Web of Science ®Google Scholar
• Shortman K, Wu L. Early T lymphocyte progenitors. Annu Rev Immunol. 1996;14:29–47.
   PubMed Web of Science ®Google Scholar
• Wu CY, Warrier RR, Carvajal DM, Biological function and distribution of human interleukin-12 receptor b chain. Eur J Immunol. 1996;246:345–350.
   Google Scholar
• Moore TA, Zlotnik A. T-cell lineage commitment and cytokine responses of thymic progenitors. Blood. 1995;86:1850–1860.
   PubMed Web of Science ®Google Scholar
• Lee CK, Kim JK, Kim Y, Generation of macrophages from early T progenitors in vitro. J Immunol. 2001;166:5964–5969.
   PubMedGoogle Scholar
• Schmitt TM, Ciofani M, Petrie HT, Zúñiga-Pflücker JC. Maintenance of T cell specification and differentiation requires recurrent notch receptor-ligand interactions. J Exp Med. 2004;200:469–479.
   PubMed Web of Science ®Google Scholar
• Talebian L, Li Z, Guo Y, T-lymphoid, megakaryocyte, and granulocyte development are sensitive to decreases in CBFbeta dosage. Blood. 2007;109:11–21.
   PubMedGoogle Scholar
• Bender TP, Kremer CS, Kraus M, Buch T, Rajewsky K. Critical functions for c-Myb at three checkpoints during thymocyte development. Nat Immunol. 2004;5:721–729.
   PubMed Web of Science ®Google Scholar
• Anderson G, Jenkinson WE, Jones T, Establishment and functioning of intrathymic microenvironments. Immunol Rev. 2006;209:10–27.
   PubMedGoogle Scholar
• von Boehmer H, Fehling HJ. Structure and function of the pre-T cell receptor. Annu Rev Immunol. 1997;15:433–452.
   PubMed Web of Science ®Google Scholar
• Zúñiga-Pflücker JC, Lenardo MJ. Regulation of thymocyte development from immature progenitors. Curr Opin Immunol. 1996;8:215–224.
   PubMed Web of Science ®Google Scholar
• Fehling HJ, von Boehmer H. Early alpha beta T cell development in the thymus of normal and genetically altered mice. Curr Opin Immunol. 1997;9:263–275.
   PubMed Web of Science ®Google Scholar
• Kisielow P, Teh HS, Blüthmann H, von Boehmer H. Positive selection of antigen-specific T cells in thymus by restricting MHC molecules. Nature. 1988;335:730–733.
   PubMed Web of Science ®Google Scholar
• Jameson SC, Hogquist KA, Bevan MJ. Positive selection of thymocytes. Annu Rev Immunol. 1995;13:93–126.
   PubMed Web of Science ®Google Scholar
• Reichert RA, Weissman IL, Butcher EC. Phenotypic analysis of thymocytes that express homing receptors for peripheral lymph nodes. J Immunol. 1986;136:3521–3528.
   PubMed Web of Science ®Google Scholar
• Bendelac A, Matzinger P, Seder RA, Paul WE, Schwartz RH. Activation events during thymic selection. J Exp Med. 1992;175:731–742.
   PubMed Web of Science ®Google Scholar
• Ramsdell F, Jenkins M, Dinh Q, Fowlkes BJ. The majority of CD4+8− thymocytes are functionally immature. J Immunol. 1991;147:1779–1785.
   PubMedGoogle Scholar
• Griesemer AD, Sorenson EC, Hardy MA. The role of the thymus in tolerance. Transplantation. 2010;90:465–474.
   PubMed Web of Science ®Google Scholar
• Cheroutre H. Starting at the beginning: new perspectives on the biology of mucosal T cells. Annu Rev Immunol. 2004;22:217–246.
   PubMed Web of Science ®Google Scholar
• Franki AS, Van Beneden K, Dewint P, Lymphotoxin alpha 1 beta 2: a critical mediator in V alpha 14i NKT cell differentiation. Mol Immunol. 2005;42:413–417.
   PubMedGoogle Scholar
• Baldwin TA, Hogquist KA, Jameson SC. The fourth way? Harnessing aggressive tendencies in the thymus. J Immunol. 2004;173:6515–6520.
   PubMedGoogle Scholar
• Brewer JA, Kanagawa O, Sleckman BP, Muglia LJ. Thymocyte apoptosis induced by T cell activation is mediated by glucocorticoids in vivo. J Immunol. 2002;169:1837–1843.
   PubMed Web of Science ®Google Scholar
• Martin S, Bevan MJ. Antigen-specific and nonspecific deletion of immature cortical thymocytes caused by antigen injection. Eur J Immunol. 1997;27:2726–2736.
   PubMedGoogle Scholar
• Palmer E. Negative selection—clearing out the bad apples from the T-cell repertoire. Nat Rev Immunol. 2003;3:383–391.
   PubMed Web of Science ®Google Scholar
• Hammerling GJ. Non-deletional mechanisms of peripheral and central tolerance: studies with transgenic mice with tissue-specific expression of a foreign MHC class I antigen. Immunol Rev. 1991;122:47–67.
   PubMedGoogle Scholar
• McGargill MA, Derbinski JM, Hogquist KA. Receptor editing in developing T cells. Nat Immunol. 2000;1:336–341.
   PubMedGoogle Scholar
• Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol. 2005;6:345–352.
   PubMed Web of Science ®Google Scholar
• Pignata C, Troncone R, Monaco G, Impaired suppressor activity in children affected by coeliac disease. Gut. 1985;26:285–290.
   PubMedGoogle Scholar
• Derbinski J, Schulte A, Kyewski B, Klein L. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol. 2001;2:1032–1039.
   PubMed Web of Science ®Google Scholar
• Derbinski J, Gabler J, Brors B, Promiscuous gene expression in thymic epithelial cells is regulated at multiple levels. J Exp Med. 2005;202:33–45.
   PubMed Web of Science ®Google Scholar
• Gray DH, Seach N, Ueno T, Developmental kinetics, turnover, and stimulatory capacity of thymic epithelial cells. Blood. 2006;108:3777–3785.
   PubMed Web of Science ®Google Scholar
• Gray D, Abramson J, Benoist C, Mathis D. Proliferative arrest and rapid turnover of thymic epithelial cells expressing Aire. J Exp Med. 2007;204:2521–2528.
   PubMed Web of Science ®Google Scholar
• Anderson MS, Veneziani ES, Klein L, Projection of an immunological self shadow within the thymus by the aire protein. Science. 2002;298:1395–1401.
   PubMed Web of Science ®Google Scholar
• Coutinho A, Caramalho I, Seixas E, Demengeot J. Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection. Curr Top Microbiol Immunol. 2005;293:43–71.
   PubMed Web of Science ®Google Scholar
• Derbinski J, Pinto S, Rösch S, Hexel K, Kyewski B. Promiscuous gene expression patterns in single medullary thymic epithelial cells argue for a stochastic mechanism. Proc Natl Acad Sci U S A. 2008;105:657–662.
   PubMed Web of Science ®Google Scholar
• Gabler J, Arnold J, Kyewski B. Promiscuous gene expression and the developmental dynamics of medullary thymic epithelial cells. Eur J Immunol. 2007;37:3363–3372.
   PubMedGoogle Scholar
• Gillard GO, Farr AG. Features of medullary thymic epithelium implicate postnatal development in maintaining epithelial heterogeneity and tissue-restricted antigen expression. J Immunol. 2006;176:5815–5824.
   PubMed Web of Science ®Google Scholar
• Kyewski B, Peterson P. Aire, master of many trades. Cell. 2010;140:24–26.
   PubMed Web of Science ®Google Scholar
• Mathis D, Benoist C. A decade of AIRE. Nat Rev Immunol. 2007;7:645–650.
   PubMed Web of Science ®Google Scholar
• Mathis D, Benoist C. Aire. Annu Rev Immunol. 2009;27:287–312.
   PubMed Web of Science ®Google Scholar
• Villaseñor J, Besse W, Benoist C, Mathis D. Ectopic expression of peripheral-tissue antigens in the thymic epithelium: probabilistic, monoallelic, misinitiated. Proc Natl Acad Sci U S A. 2008;105:15854–15859.
   Google Scholar
• Rooke R, Waltzinger C, Benoist C, Mathis D. Targeted complementation of MHC class II deficiency by intrathymic delivery of recombinant adenoviruses. Immunity. 1997;7:123–134.
   PubMed Web of Science ®Google Scholar
• Scollay R, Godfrey DI. Thymic emigration: conveyor belts or lucky dips? Immunol Today. 1995;16:268–274.
   PubMedGoogle Scholar
• Klein L. Dead man walking: how thymocytes scan the medulla. Nat Immunol. 2009;10:809–811.
   PubMed Web of Science ®Google Scholar
• Koble C, Kyewski B. The thymic medulla: a unique microenvironment for intercellular self-antigen transfer. J Exp Med. 2009;206:1505–1513.
   PubMed Web of Science ®Google Scholar
• Millet V, Naquet P, Guinamard RR. Intercellular MHC transfer between thymic epithelial and dendritic cells. Eur J Immunol. 2008;38:1257–1263.
   PubMedGoogle Scholar
• Fontenot JD, Rudensky AY. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol. 2005;6:331–337.
   PubMed Web of Science ®Google Scholar
• Liu H, Leung BP. CD4+CD25+ regulatory T cells in health and disease. Clin Exp Pharmacol Physiol. 2006;33:519–524.
   PubMed Web of Science ®Google Scholar
• Cabarrocas J, Cassan C, Magnusson F, Foxp3+ CD25+ regulatory T cells specific for a neo-self-antigen develop at the double-positive thymic stage. Proc Natl Acad Sci U S A. 2006;30:8453–8458.
   Google Scholar
• Jordan MS, Boesteanu A, Reed AJ, Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol. 2001;2:301–306.
   Google Scholar
• Caton AJ, Cozzo C, Larkin J, Lerman MA, Boesteanu A, Jordan MS. CD4(+) CD25(+) regulatory T cell selection. Ann N Y Acad Sci. 2004;1029:101–114.
   PubMedGoogle Scholar
• D'Cruz LM, Klein L. Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling. Nat Immunol. 2005;6:1152–1159.
   PubMed Web of Science ®Google Scholar
• Kim JM, Rudensky A. The role of the transcription factor Foxp3 in the development of regulatory T cells. Immunol Rev. 2006;212:86–98.
   PubMed Web of Science ®Google Scholar
• Van Santen HM, Benoist C, Mathis D. Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells. J Exp Med. 2004;200:1221–1230.
   PubMed Web of Science ®Google Scholar
• Foy TM, Page DM, Waldschmidt TJ, An essential role for gp39, the ligand for CD40, in thymic selection. J Exp Med. 1995;182:1377–1388.
   PubMed Web of Science ®Google Scholar
• Page DM, Roberts EM, Peschon JJ, Hedrick SM. TNF receptor-deficient mice reveal striking differences between several models of thymocyte negative selection. J Immunol. 1998;160:120–133.
   PubMedGoogle Scholar
• Matzinger P, Guerder S. Does T-cell tolerance require a dedicated antigen-presenting cell? Nature. 1989;338:74–76.
   PubMed Web of Science ®Google Scholar
• Kishimoto H, Sprent J. Several different cell surface molecules control negative selection of medullary thymocytes. J Exp Med. 1999;190:65–73.
   PubMed Web of Science ®Google Scholar
• Kishimoto H, Sprent J. Negative selection in the thymus includes semimature T cells. J Exp Med. 1997;185:263–271.
   PubMed Web of Science ®Google Scholar
• Kishimoto H, Surth CD, Sprent J. A role for Fas in negative selection of thymocytes in vivo. J Exp Med. 1998;187:1427–1438.
   PubMed Web of Science ®Google Scholar
• Cloosen S, Arnold J, Thio M, Bos GM, Kyewski B, Germeraad WT. Expression of tumor-associated differentiation antigens, MUC1 glycoforms and CEA, in human thymic epithelial cells: implications for self-tolerance and tumor therapy. Cancer Res. 2007;67:3919–3926.
   PubMed Web of Science ®Google Scholar
• Chentoufi AA, Palumbo M, Polychronakos C. Proinsulin expression by Hassall's corpuscles in the mouse thymus. Diabetes. 2004;53:354–359.
   PubMedGoogle Scholar
• Chentoufi AA, Polychronakos C. Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance: the mechanism by which the IDDM2 locus may predispose to diabetes. Diabetes. 2002;51:1383–1390.
   PubMed Web of Science ®Google Scholar
• Brimnes MK, Jensen T, Jørgensen TN, Michelsen BK, Troelsen J, Werdelin O. Low expression of insulin in the thymus of non-obese diabetic mice. J Autoimmun. 2002;19:203–213.
   PubMedGoogle Scholar
• Giraud M, Taubert R, Vandiedonck C, An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus. Nature. 2007;448:934–937.
   PubMed Web of Science ®Google Scholar
• Anderson AC, Nicholson LB, Legge KL, Turchin V, Zaghouani H, Kuchroo VK. High frequency of autoreactive myelin proteolipid protein-specific T cells in the periphery of naive mice: mechanisms of selection of the self-reactive repertoire. J Exp Med. 2000;191:761–770.
   PubMedGoogle Scholar
• Klein L, Klugmann M, Nave KA, Tuohy VK, Kyewski B. Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells. Nat Med. 2000;6:56–61.
   PubMed Web of Science ®Google Scholar
• Sakaguchi N, Takahashi T, Hata H, Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature. 2003;426:454–460.
   PubMed Web of Science ®Google Scholar
• Calanan B, Szychowski S, Chan FK, Cado D, Winoto A. A role for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-induced negative selection. Immunity. 1995;3:273–282.
   PubMedGoogle Scholar
• Cavadini P, Vermi W, Facchetti F, AIRE deficiency in thymus of 2 patients with Omenn syndrome. J Clin Invest. 2005;115:728–732.
   PubMed Web of Science ®Google Scholar
• Honig M, Schwarz K. Omenn syndrome: a lack of tolerance on the background of deficient lymphocyte development and maturation. Curr Opin Rheumatol. 2006;18:383–388.
   PubMedGoogle Scholar
• Davies JK, Telfer P, Cavenagh JD, Foot N, Neat M. Autoimmune cytopenias in the 22q11.2 deletion syndrome. Clin Lab Haematol. 2003;25:195–197.
   PubMedGoogle Scholar
• Sakamoto O, Imaizumi M, Suzuki A, Refractory autoimmune hemolytic anemia in a patient with chromosome 22q11.2 deletion syndrome. Pediatr Int. 2004;46:612–614.
   PubMedGoogle Scholar
• Sullivan KE, McDonald-McGinn DM, Driscoll DA, Juvenile rheumatoid arthritis-like polyarthritis in chromosome 22q11.2 deletion syndrome (DiGeorge anomalad/velocardiofacial syndrome/conotruncal anomaly face syndrome). Arthritis Rheum. 1997;40:430–436.
   PubMedGoogle Scholar
• Brown JJ, Datta V, Browning MJ, Swift PG. Graves’ disease in DiGeorge syndrome: patient report with a review of endocrine autoimmunity associated with 22q11.2 deletion. J Pediatr Endocrinol Metab. 2004;17:1575–1579.
   PubMedGoogle Scholar
• Jawad AF, McDonald-McGinn DM, Zackai E, Sullivan KE. Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). J Pediatr. 2001;139:715–723.
   PubMed Web of Science ®Google Scholar
• Gennery AR. Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome. Arch Dis Child. 2002;86:422–425.
   PubMed Web of Science ®Google Scholar
• McLean-Tooke A, Spickett GP, Gennery AR. Immunodeficiency and autoimmunity in 22q11.2 deletion syndrome. Scand J Immunol. 2007;66:1–7.
   PubMed Web of Science ®Google Scholar
• Kramradt T, Goggel R, Erb KJ. Induction, exacerbation and inhibition of allergic and autoimmune diseases by infection. Trends Immunol. 2005;26:260–267.
   PubMedGoogle Scholar
• McLean-Tooke A, Barge D, Spickett GP, Gennery AR. Immunologic defects in 22q11.2 deletion syndrome. J Allergy Clin Immunol. 2008;122:362–367.
   PubMedGoogle Scholar
• Nagamine K, Peterson P, Scott HS, Positional cloning of the APECED gene. Nat Genet. 1997;17:393–398.
   PubMed Web of Science ®Google Scholar
• Finnish-German APECED Consortium. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet. 1997;17:399–403.
   PubMedGoogle Scholar
• Aaltonen J, Horelli-Kuitunen N, Fan JB, High-resolution physical and transcriptional mapping of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy locus on chromosome 21q22.3 by FISH. Genome Res. 1997;7:820–829.
   PubMed Web of Science ®Google Scholar
• Ferguson BJ, Alexander C, Rossi SW, AIRE's CARD revealed, a new structure for central tolerance provokes transcriptional plasticity. J Biol Chem. 2008;283:1723–1731.
   PubMed Web of Science ®Google Scholar
• Pitkenen J, Rebane A, Rowell J, Cooperative activation of transcription by autoimmune regulator AIRE and CBP. Biochem Biophys Res Commun. 2005;333:944–953.
   PubMedGoogle Scholar
• Ramsey C, Burkrinsky A, Peltonen L. Systematic mutagenesis of the functional domains of AIRE reveals their role in intracellular targeting. Hum Mol Genet. 2002;11:3299–3308.
   PubMed Web of Science ®Google Scholar
• Gibson TJ, Ramu C, Gemund C, Aasland R. The APECED polyglandular autoimmune syndrome protein, AIRE-1, contains the SAND domain and is probably a transcription factor. Trends Biochem Sci. 1998;23:242–244.
   PubMed Web of Science ®Google Scholar
• Ilmarinen T, Eskelin P, Halonen M, Functional analysis of SAND mutations in AIRE supports dominant inheritance of the G228W mutation. Hum Mutat. 2005;26:322–331.
   PubMed Web of Science ®Google Scholar
• Bottomlei MJ, Stier G, Pennacchini D, NMR structure of the first PHD finger of autoimmune regulator protein (AIRE1): insights into autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) disease. J Biol Chem. 2005;280:11505–11512.
   PubMedGoogle Scholar
• Bjorses P, Halonen M, Palvimo JJ, Mutation in the AIRE gene: effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protein. Am J Hum Genet. 2000;66:378–392.
   PubMed Web of Science ®Google Scholar
• Meloni A, Incani F, Corda D, Cao A, Rosatelli MC. Role of PHD fingers and COOH-terminal 30 amino acids in AIRE transactivation activity. Mol Immunol. 2008;45:805–809.
   PubMed Web of Science ®Google Scholar
• Halonen M, Kangas H, Ruppell T, APECED-causing mutations in AIRE reveal the functional domains of the protein. Hum Mutat. 2004;23:245–257.
   PubMedGoogle Scholar
• Uchida D, Hatakeyama S, Matsushima A, AIRE functions as an E3 ubiquitin ligase. J Exp Med. 2004;199:167–172.
   PubMed Web of Science ®Google Scholar
• Savkur RS, Burris TP. The coactivator LXXLL nuclear receptor recognition motif. J Pept Res. 2004;63:207–212.
   PubMedGoogle Scholar
• Johnnidis JB, Venanzi ES, Taxman DJ, Ting JP, Benoist CO, Mathis DJ. Chromosomal clustering of genes controlled by the aire transcription factor. Proc Natl Acad Sci USA. 2005;17:7233–7238.
   Google Scholar
• Abramson J, Giraud M, Benoist C, Mathis D. Aire's partners in the molecular control of immunological tolerance. Cell. 2010;140:123–135.
   PubMed Web of Science ®Google Scholar
• Pitkanen J, Vahamurto P, Krohn K, Peterson P. Subcellular localization of the autoimmune regulator protein: characterization of nuclear targeting and transcriptional activation domain. J Biol Chem. 2001;276:19597–19602.
   PubMed Web of Science ®Google Scholar
• Kalkhoven E. CBP and p300: HATs for different occasions. Biochem Pharmacol. 2004;68:1145–1155.
   PubMed Web of Science ®Google Scholar
• Peterson P, Org T, Rebane A. Transcriptional regulation by AIRE: molecular mechanisms of central tolerance. Nat Rev Immunol. 2008;8:948–957.
   PubMed Web of Science ®Google Scholar
• Liiv I, Rebane A, Org T, DNA-PK contributes to the phosphorylation of AIRE: importance in transcriptional activity. Biochim Biophys Acta. 2008;1783:74–83.
   PubMed Web of Science ®Google Scholar
• Ilmarinen T, Kangas H, Kytomaa T, Functional interaction of AIRE with PIAS1 in transcriptional regulation. Mol Immunol. 2008;45:1847–1862.
   PubMed Web of Science ®Google Scholar
• Oven I, Brdickova N, Khoutek J, Vaupotic T, Narat M, Peterlin BM. AIRE recruits P-TEFb for transcriptional elongation of target genes in medullary thymic epithelial cells. Mol Cell Biol. 2007;27:8815–8823.
   PubMed Web of Science ®Google Scholar
• Mellor J. It takes a PHD to read the histone code. Cell. 2006;126:22–24.
   PubMed Web of Science ®Google Scholar
• Org T, Chignola F, Hetenyi C, The autoimmune regulator PHD finger binds to non-methylated histone H3K4 to activate gene expression. EMBO Rep. 2008;9:370–376.
   PubMedGoogle Scholar
• Koh AS, Kuo AJ, Park SY, Aire employs a histone-binding module to mediate immunological tolerance, linking chromatin regulation with organ-specific autoimmunity. Proc Natal Acad Sci USA. 2008;105:15878–15883.
   PubMed Web of Science ®Google Scholar
• Cohen JN, Guidi CJ, Tewalt EF, Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation. J Exp Med. 2010;207:681–688.
   PubMed Web of Science ®Google Scholar
• Seach N, Ueno T, Fletcher AL, The lymphotoxin pathway regulates Aire-independent expression of ectopic genes and chemokines in thymic stromal cells. J Immunol. 2008;180:5384–5392.
   PubMedGoogle Scholar
• Kim SH, Jeong JW, Park JA, Regulation of the HIF-1alpha stability by histone deacetylases. Oncol Rep. 2007;17:647–651.
   PubMed Web of Science ®Google Scholar
• Eldershaw SA, Sansom DM, Narendran P. Expression and function of the autoimmune regulator (Aire) gene in non-thymic tissue. Clin Exp Immunol. 2011;163:296–308.
   PubMed Web of Science ®Google Scholar
• Wang CY, Shi JD, Davoodi-Semiromi A, She JX. Cloning of Aire, the mouse homologue of the autoimmune regulator (AIRE) gene responsible for autoimmune polyglandular syndrome type 1 (ASP1). Genomics. 1999;55:322–326.
   PubMed Web of Science ®Google Scholar
• Mittaz L, Rossier C, Heino M, Isolation and characterization of the mouse Aire gene. Biochem Biophys Res Commun. 1999;255:483–490.
   PubMed Web of Science ®Google Scholar
• Kuroda N, Mitani T, Takeda N, Development of autoimmunity against transcriptionally unrepressed target antigen in the thymus of Aire-deficient mice. J Immunol. 2005;174:1862–1870.
   PubMed Web of Science ®Google Scholar
• Pöntynen N, Miettinen A, Arstila TP, Aire deficient mice do not develop the same profile of tissue-specific autoantibodies as APECED patients. J Autoimmun. 2006;27:96–104.
   PubMed Web of Science ®Google Scholar
• Zhang B, Yamamura T, Kondo T, Fujiwara M, Tabira T. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J Exp Med. 1997;186:1677–1687.
   PubMed Web of Science ®Google Scholar
• Smeltz RB, Wolf NA, Swanborg RH. Inhibition of autoimmune T cell responses in the DA rat by bone marrow-derived NK cells in vitro: implications for autoimmunity. J Immunol. 1999;163:1390–1397.
   PubMed Web of Science ®Google Scholar
• Pignata C, Prasad KVS, Hallek M, Phosphorylation of src family lck tyrosine kinase following interleukin-12 activation of human natural killer cells. Cell Immunol. 1995;165:211–216.
   PubMedGoogle Scholar
• Fort MM, Leach MW, Rennick DM. A role for NK cells as regulators of CD4+ T cells in a transfer model of colitis. J Immunol. 1998;161:3256–3261.
   PubMed Web of Science ®Google Scholar
• Aloj G, Giardino G, Valentino L, Severe combined immunodeficiences: new and old scenarios. Int Rev Immunol. 2012;31:43–65.
   PubMed Web of Science ®Google Scholar
• Mathew P, Crist WM, Furman WL. The use in cytokines in children. Curr Opin Pediatr. 1994;6:58–67.
   PubMedGoogle Scholar
• Perheentupa J. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab. 2006;91:2843–2850.
   PubMed Web of Science ®Google Scholar
• Betterle C, Greggio NA, Volpato M. Autoimmune polyglandular syndrome type 1. J Clin Endocr Metab. 1998;83:1049–1055.
   PubMed Web of Science ®Google Scholar
• Ahonen P, Myllarniemi S, Sipila I, Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med. 1990;322:1829–1836.
   PubMed Web of Science ®Google Scholar
• Tóth B, Wolff AS, Halász Z, Novel sequence variation of AIRE and detection of interferon-omega antibodies in early infancy. Clin Endocrinol (Oxf). 2010;72:641–647.
   PubMed Web of Science ®Google Scholar
• Wolff AS, Erichsen MM, Meager A, Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene. J Clin Endocrinol Metab. 2007;92:595–603.
   PubMed Web of Science ®Google Scholar
• Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev. 2002;23:327–364.
   PubMed Web of Science ®Google Scholar
• Kisand K, Bøe Wolff AS, Podkrajsek KT, Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J Exp Med. 2010;207:299–308.
   PubMed Web of Science ®Google Scholar
• Puel A, Döffinger R, Natividad A, Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med. 2010;207:291–297.
   PubMed Web of Science ®Google Scholar
• Husebye ES, Perheentupa J, Rautemaa R, Kämpe O. Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. J Intern Med. 2009;265:514–529.
   PubMed Web of Science ®Google Scholar
• Bensing S, Brandt L, Tabaroj F, Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency. Clin Endocrinol (Oxf). 2008;69:697–704.
   PubMed Web of Science ®Google Scholar
• Rautemaa R, Hietanen J, Niissalo S, Pirinen S, Perheentupa J. Oral and oesophageal squamous cell carcinoma—a complication or component of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED, APS-I). Oral Oncol. 2007;43:607–613.
   PubMed Web of Science ®Google Scholar
• Lankisch TO, Jaeckel E, Strassburg CP. The autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy or autoimmune polyglandular syndrome type 1. Semin Liver Dis. 2009; 29:307–314.
   PubMedGoogle Scholar
• Capalbo D, Mazza C, Giordano R, Molecular background and genotype-phenotype correlation in APECED patients from Campania and in their relatives. J Endocrinol Invest. 2011; 35:169–173.
   PubMedGoogle Scholar
• Capalbo D, Elefante A, Spagnuolo MI, Posterior reversible encephalopathy syndrome in a child during an accelerated phase of a severe APECED phenotype due to an uncommon mutation of AIRE. Clin Endocrinol (Oxf). 2008;69:511–513.
   PubMedGoogle Scholar
• Gavanescu I, Benoist C, Mathis D. B cells are required for Aire-deficient mice to develop multi-organ autoinflammation: a therapeutic approach for APECED patients. Proc Natl Acad Sci USA. 2008;105:13009–13014.
   PubMedGoogle Scholar
• Devoss JJ, Shum AK, Johannes KP, Effector mechanisms of the autoimmune syndrome in the murine model of autoimmune polyglandular syndrome type 1. J Immunol. 2008;181:4072–4079.
   PubMed Web of Science ®Google Scholar
• Zlotogora J, Shapiro MS. Polyglandular autoimmune syndrome type I among Iranian Jews. J Med Genet. 1992;29:824–826.
   PubMed Web of Science ®Google Scholar
• Aaltonen J, Bjorses P, Sandkuijl L, Perheentupa J, Peltonen L. An autosomal locus causing autoimmune disease: autoimmune polyglandular disease type I assigned to chromosome 21. Nat Genet. 1994;8:83–87.
   PubMed Web of Science ®Google Scholar
• Rosatelli MC, Meloni A, Devoto M, A common mutation in Sardinian autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients. Hum Genet. 1998;103:428–434.
   PubMed Web of Science ®Google Scholar
• Cetani F, Barbesino G, Borsari S, A novel mutation of the autoimmune regulator gene in an Italian kindred with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, acting in a dominant fashion and strongly cosegregating with hypothyroid autoimmune thyroiditis. J Clin Endocr Metab. 2001;86:4747–4752.
   PubMed Web of Science ®Google Scholar
• Podkrajses KT, Bratanic N, Krzisnik C, Battelino T. Autoimmune regulator-1 messenger ribonucleic acid analysis in a novel intronic mutation and two additional novel AIRE gene mutations in a cohort of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients. J Clin Endocr Metab. 2005;90:4930–4935.
   PubMedGoogle Scholar
• Stolarski B, Pronicka E, Korniszewski L, Molecular background of polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome in a Polish population: novel AIRE mutations and an estimate of disease prevalence. Clin Genet. 2006;70:348–354.
   PubMedGoogle Scholar
• Scott HS, Heino M, Peterson P, Common mutations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients of different origins. Mol Endocrinol. 1998;12:1112–1119.
   PubMedGoogle Scholar
• Pearce SH, Cheetham T, Imrie H, A common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinopathy type 1. Am J Hum Genet. 1998;63:1675–1684.
   PubMed Web of Science ®Google Scholar
• Dominguez M, Crushell E, Ilmarinen T, Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in the Irish population. J Pediatr Endocrinol Metab. 2006;19: 1343–1352.
   PubMedGoogle Scholar
• Wang CY, Davoodi-Semiromi A, Huang W, Connor E, Shi JD, She JX. Characterization of mutations in patients with autoimmune polyglandular syndrome type 1 (APS1). Hum Genet. 1998;103:681–685.
   PubMed Web of Science ®Google Scholar
• Heino M, Scott HS, Chen Q, Mutation analyses of North American APS-1 patients. Hum Mutat. 1999;13:69–74.
   PubMedGoogle Scholar
• Clemente MG, Meloni A, Obermayer-Straub P, Frau F, Manns MP, De Virgilis S. Two cytochromes P450 are major hepatocellular autoantigens in autoimmune polyglandular syndrome type 1. Gastroenterology. 1998;114:324–328.
   PubMed Web of Science ®Google Scholar
• Meloni A, Willcox N, Meager A, Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in Sardinian patients. J Clin Endocr Metab. 2012;97:1114–1124.
   PubMed Web of Science ®Google Scholar
• Meloni A, Perniola R, Faa V, Corvaglia E, Cao A, Rosatelli MC. Delineation of the molecular defects in the AIRE gene in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients from Southern Italy. J Clin Endocrinol Metab. 2002;87:841–846.
   PubMed Web of Science ®Google Scholar
• Cervato S, Mariniello B, Lazzarotto F, Evaluation of the autoimmune regulator (AIRE) gene mutations in a cohort of Italian patients with autoimmune-polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) and in their relatives. Clin Endocrinol (Oxf). 2009;70:421–428.
   PubMed Web of Science ®Google Scholar
• Giordano C, Modica R, Allotta ML, Autoimmune polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) in Sicily: confirmation that R203X is the peculiar AIRE gene mutation. J Endocrinol Invest. 2011;35:384–388.
   PubMedGoogle Scholar
• Valenzise M, Wasniewska M, Mirabelli S, De Luca F, Cervato S, Betterle C. Identification of two novel mutations in the first Sicilian APECED patient with no R203X mutation in AIRE gene and review of Italian APECED genotypes. Gene. 2012;499:343–346.
   PubMedGoogle Scholar
• Betterle C, Ghizzoni L, Cassio A, Autoimmune-polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) in Calabria: clinical, immunological and genetic patterns. J Endocrinol Invest. [Nov 21, 2011. Epub ahead of print].
   Google Scholar
• Ishii T, Suzuki Y, Ando N, Matsuo N, Ogata T. Novel mutations of the autoimmune regulator gene in two siblings with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocr Metab. 2000;85:2922–2926.
   PubMedGoogle Scholar
• Halonen M, Eskelin P, Myhre AG, AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype. J Clin Endocrinol Metab. 2002;87:2568–2574.
   PubMed Web of Science ®Google Scholar
• Kekalainen E, Tuovinen H, Joensuu J, A defect of regulatory T cells in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Immunol. 2007;178:1208–1215.
   PubMed Web of Science ®Google Scholar
• Russell JH, Rush B, Weaver C, Wang R. Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc Natl Acad Sci U S A. 1993;90:4409–4413.
   PubMed Web of Science ®Google Scholar
• Pignata C, Fiore M, De Filippo S, Cavalcanti M, Gaetaniello L, Scotese I. Apoptosis as a mechanism of peripheral blood mononuclear cell death following measles and varicella-zoster virus infections in children. Pediatr Res. 1998;43:77–83.
   PubMed Web of Science ®Google Scholar
• Giardino G, Aloj G, Cirillo E, Intergenerational anticipation of disease onset in people with multiple autoimmune syndrome. Diabetes Res Clin Pract. 2011;94:37–39.
   Google Scholar